Axsome Therapeutics, Inc (AXSM) Total Assets by Year
Axsome Therapeutics, Inc closed fiscal year 2025 with $689.8M in total assets, $601.5M in total liabilities and $88.3M in shareholder equity. This represents an increase of 21.3% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Axsome Therapeutics, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AXSM Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY21DEF 14A | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $689.8M+21.3% | $568.5M-3.4% | $588.2M+77.5% | $331.5M+277.6% | $87.8M-52.8% | $186.1M-15.6% | $220.5M+1334.1% | $15.4M-56.7% | $35.6M-7.0% | $38.2M-22.1% | $49.1M | N/A |
| Total Liabilities | $601.5M+17.6% | $511.5M+28.8% | $397.3M+79.0% | $221.9M+207.6% | $72.2M-0.3% | $72.3M+73.0% | $41.8M+189.6% | $14.4M-23.3% | $18.8M+13.2% | $16.6M+532.3% | $2.6M | N/A |
| Total Equity | $88.3M+54.9% | $57.0M-70.1% | $191.0M+74.3% | $109.6M+600.9% | $15.6M-86.3% | $113.8M-36.3% | $178.7M+18955.2% | $938K-94.4% | $16.7M-22.5% | $21.6M-53.6% | $46.4M+1550.2% | -$3.2M |
AXSM Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $761.4M+19.0% | $713.6M+19.6% | $689.8M+21.3% | $669.3M+19.2% | $639.8M+16.7% | $596.7M+9.3% | $568.5M-3.4% | $561.5M-6.6% | $548.2M-10.4% | $545.7M+40.2% | $588.2M+77.5% | $600.9M+77.3% |
| Total Liabilities | $678.1M+19.7% | $659.0M+21.3% | $601.5M+17.6% | $595.5M+27.1% | $566.7M+27.2% | $543.5M+35.3% | $511.5M+28.8% | $468.6M+41.4% | $445.4M+33.8% | $401.7M+44.8% | $397.3M+79.0% | $331.3M+82.5% |
| Total Equity | $83.3M+14.0% | $54.6M+2.6% | $88.3M+54.9% | $73.7M-20.6% | $73.1M-29.0% | $53.2M-63.1% | $57.0M-70.1% | $92.9M-65.5% | $102.9M-63.1% | $144.0M+28.8% | $191.0M+74.3% | $269.5M+71.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Axsome Therapeutics, Inc financials
Frequently Asked Questions
What was Axsome Therapeutics, Inc's total assets in fiscal year 2025?
Axsome Therapeutics, Inc closed fiscal year 2025 with $689.8M in total assets, $601.5M in total liabilities and $88.3M in shareholder equity.
How fast is Axsome Therapeutics, Inc's total assets growing?
Axsome Therapeutics, Inc (AXSM) total assets rose by 21.3% year over year, from $568.5M to $689.8M in fiscal year 2025.
What was Axsome Therapeutics, Inc's total assets in the most recent quarter?
Axsome Therapeutics, Inc (AXSM) reported $761.4M in total assets in Q2 2026. This represents an increase of 19.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Axsome Therapeutics, Inc (AXSM) reported on that line in every period on record.